1031771-45-5

Basic information

• Product Name: N-(4-N-BOC-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide
• Synonyms: N-(4-N-BOC-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide
• CAS NO: 1031771-45-5
• Molecular Weight: 482.623
• Mol File: 1031771-45-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(4-N-BOC-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-N-BOC-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide(1031771-45-5)
• EPA Substance Registry System: N-(4-N-BOC-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide(1031771-45-5)

Safety Data

• Hazardous Substances Data: 1031771-45-5(Hazardous Substances Data)

Upstream product

• 94838-55-8 tert-butyl (4-aminobenzyl)carbamate 
• 229006-88-6 2-(4-methylphenyl)-6,7-dihydro-5H-benzocycloheptene-8-carboxylic acid 

Downstream Products

• 1031771-48-8 N-(4-aminomethylphenyl)-2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-carboxamide 

Relevant articles and documents

Inhibition of HIV fusion with multivalent gold nanoparticles

The design and synthesis of a multivalent gold nanoparticle therapeutic is presented. SDC-1721, a fragment of the potent HIV inhibitor TAK-779, was synthesized and conjugated to 2.0 nm diameter gold nanoparticles. Free SDC-1721 had no inhibitory effect on HIV infection; however, the (SDC-1721)-gold nanoparticle conjugates displayed activity comparable to that of TAK-779. This result suggests that multivalent presentation of small molecules on gold nanoparticle surfaces can convert inactive drugs into potent therapeutics. Copyright